“Evaluation of Pharmacokinetic and Pharmacodynamic Interaction Between Repaglinide and Atazanavir in Healthy, Diabetic and Hepatic Impaired Rats: Possible Inhibition of CYP3A, OATP, and P-Glycoprotein Transporters”. ADMET and DMPK 4, no. 3 (October 1, 2016): 269–279. Accessed May 2, 2026. https://pub.iapchem.org/ojs/index.php/admet/article/view/328.